Targeting Lewy body dementia with neflamapimod-rasagiline hybrids.
Albertini C, Petralla S, Massenzio F, Monti B, Rizzardi N, Bergamini C, Uliassi E, Borges F, Chavarria D, Fricker G, Goettert M, Kronenberger T, Gehringer M, Laufer S, Bolognesi ML.
Albertini C, et al. Among authors: rizzardi n.
Arch Pharm (Weinheim). 2024 Jun;357(6):e2300525. doi: 10.1002/ardp.202300525. Epub 2024 Feb 27.
Arch Pharm (Weinheim). 2024.
PMID: 38412454